Similarly, in both gastric cancer cells and mouse-transplanted tumor models, Anlotinib has shown efficacy in reducing tumor proliferation and metastasis by activating the cGAS-STING signaling pathway [53]. This evidence concerns the gene STING1 and neoplasm.